Elan's Alzheimer's-Fueled Run Means Investors Are Forgetting the Past

Monday, March 19th, 2012

Remembering the failed back story of Elan's Alzheimer's drug bapineuzumab as phase III trial results loom. Click to view a price quote on ELN . Click to research the Drugs industry.

See the rest here:
Elan's Alzheimer's-Fueled Run Means ... continue reading

Alzheimer's drugs may have serious side-effects

Monday, February 20th, 2012

Washington, Feb 20 (IANS) Drugs for Alzheimer's disease currently undergoing clinical trials may have adverse side-effects, warns a new study.

Continue reading here:
Alzheimer's drugs may have serious side-effects

Tags: alzheimer, trials-may, undergoing-clinical, ... continue reading

Alzheimer's drugs may have adverse side effects

Sunday, February 19th, 2012

( Northwestern University ) Alzheimer's disease drugs now being tested in clinical trials may have potentially adverse side effects. A study with mice suggests the drugs could act like a bad electrician, causing neurons to be miswired and interfering with their ability to send messages to the brain. Ironically, they ... continue reading

Research and Markets: Alzheimer’s Disease Patients & Market Worldwide, Future Scenario 2010-2015 – Global Alzheimer’s …

Tuesday, June 14th, 2011

Research and Markets has announced the addition of the “Alzheimer’s Disease Patients & Market Worldwide, Future Scenario & Drugs Analysis” report to their offering.

More here:
Research and Markets: Alzheimer’s Disease Patients ... continue reading